2002 - Editors Choice

Citations 1-8 of 8 total displayed.

Most recent content (1 Dec 2002):

Lung cancer
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients

P. J. Souquet, E. H. Tan, J. Rodrigues Pereira, R. Van Klaveren, A. Price, U. Gatzemeier, M. Jaworski, J. P. Burillon, and D. Aubert
Ann. Onc. 2002; 13: 1853-1861. [Abstract] [Full text] [PDF]  

Past content (since Apr 2002):

Breast cancer
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

E. Heidemann, H. Stoeger, R. Souchon, W.-D. Hirschmann, H. Bodenstein, C. Oberhoff, J. T. Fischer, M. Schulze, M. Clemens, R. Andreesen, M. Mahlke, M. König, A. Scharl, K. Fehnle, and M. Kaufmann
Ann. Onc. 2002; 13: 1717-1729. [Abstract] [Full text] [PDF]  

Lung cancer
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial

R. Rosell, U. Gatzemeier, D. C. Betticher, U. Keppler, H. N. Macha, R. Pirker, P. Berthet, J. L. Breau, P. Lianes, M. Nicholson, A. Ardizzoni, A. Chemaissani, J. Bogaerts, and G. Gallant
Ann. Onc. 2002; 13: 1539-1549. [Abstract] [Full text] [PDF]  

Breast cancer
Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen

R. Arriagada, M. Spielmann, S. Koscielny, T. Le Chevalier, T. Delozier, M. Ducourtieux, T. Tursz, and C. Hill
Ann. Onc. 2002; 13: 1378-1386. [Abstract] [Full text] [PDF]  

Gastrointestinal tumors
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

M. Ducreux, P. Rougier, J.-P. Pignon, J.-Y. Douillard, J.-F. Seitz, R. Bugat, J.-F. Bosset, Y. Merouche, J.-L. Raoul, M. Ychou, A. Adenis, F. Berthault-Cvitkovic, and M. Luboinski
Ann. Onc. 2002; 13: 1185-1191. [Abstract] [Full text] [PDF]  

Epidemiology
Cancer prevalence in European registry areas

A. Micheli, E. Mugno, V. Krogh, M. J. Quinn, M. Coleman, T. Hakulinen, G. Gatta, F. Berrino, R. Capocaccia, and the EUROPREVAL Working Group
Ann. Onc. 2002; 13: 840-865. [Abstract] [Full text] [PDF]  

Breast cancer
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients

B. V. Jensen, T. Skovsgaard, and S. L. Nielsen
Ann. Onc. 2002; 13: 699-709. [Abstract] [Full text] [PDF]  

Hematologic malignancies
Relevance of intraocular involvement in the management of primary central nervous system lymphomas

A. J. M. Ferreri, J.-Y. Blay, M. Reni, F. Pasini, A. Gubkin, U. Tirelli, A. Calderoni, E. Zucca, S. Cortelazzo, C. Chassagne, M. Tinguely, B. Borisch, F. Berger, M. Ponzoni, and F. Cavalli
Ann. Onc. 2002; 13: 531-538. [Abstract] [Full text] [PDF]